These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 8399416

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Use of iotrolan versus ethiodized poppy-seed oil in hysterosalpingography.
    Lindequist S, Rasmussen F, Larsen C.
    Radiology; 1994 May; 191(2):513-7. PubMed ID: 8153331
    [Abstract] [Full Text] [Related]

  • 3. Safety and pharmacokinetics of iotrolan in hysterosalpingography. Retention and irritability compared with Lipiodol.
    Miyamoto Y, Tsujimoto T, Iwai K, Ishida K, Uchimoto R, Miyazawa T, Azuma H.
    Invest Radiol; 1995 Sep; 30(9):538-43. PubMed ID: 8537211
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Pregnancy rates after hysterosalpingography--comparing water soluble contrast medium with oily contrast medium].
    Yaegashi N, Kuramoto M, Nakayama C, Nakano M, Hoshiai H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Oct; 39(10):1812-4. PubMed ID: 2828489
    [No Abstract] [Full Text] [Related]

  • 8. Tolerance of iotrolan 190 and cerebrospinal fluid-diluted iotrolan 300 at the same iodine concentration in lumbar myelography.
    Wenzel-Hora BI, Potthoff PC, Jänicke UA.
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989 Oct; 128():148-52. PubMed ID: 2568783
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pregnancy rates after hysterosalpingography with oil- and water-soluble contrast media.
    Alper MM, Garner PR, Spence JE, Quarrington AM.
    Obstet Gynecol; 1986 Jul; 68(1):6-9. PubMed ID: 3014408
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A comparison between iotrolan, a non-ionic dimer, and a hyperosmolar contrast medium, Urografin, in hysterosalpingography.
    Brokensha C, Whitehouse G.
    Br J Radiol; 1991 Jul; 64(763):587-90. PubMed ID: 1873659
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intracranial iotrolan distribution following cervical myelography. Postmyelographic registration of adverse effects, psychometric assessment and electroencephalographic recording.
    Fiirgaard B, Madsen HH, Svare U, Eriksen FB, Skjødt T, Zeeberg I.
    Acta Radiol; 1995 Jan; 36(1):77-81. PubMed ID: 7833174
    [Abstract] [Full Text] [Related]

  • 17. Iotrolan: a blood-isotonic nonionic dimer contrast agent for peripheral angiography.
    Yamashita Y, Oguni T, Harada M, Hirai T, Korogi Y, Bussaka H, Takahashi M.
    Radiat Med; 1994 Jan; 12(3):111-4. PubMed ID: 7972893
    [Abstract] [Full Text] [Related]

  • 18. The therapeutic effects of oil-soluble hysterosalpingography contrast medium following water-soluble hysterosalpingography contrast medium.
    Yang KN, Yeh NG, Pan SB.
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Nov; 44(5):293-7. PubMed ID: 2634468
    [Abstract] [Full Text] [Related]

  • 19. [Special technics in hysterosalpingography].
    Yamaguchi R, Nishikawa Y, Moriyama I, Ohnishi Y, Ando Y.
    Rinsho Hoshasen; 1978 Nov; 23(11):1329-36. PubMed ID: 233756
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of patient reactions and diagnostic quality for hysterosalpingography using ionic and nonionic contrast media.
    Chen MY, Zagoria RJ, Fayez JA, Ott DJ, Van Swearingen FL.
    Acad Radiol; 1995 Feb; 2(2):123-7. PubMed ID: 9419535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.